1
Registered trials
1
Recruiting
1
Unique sponsors
5
Unique IMPs
1
Commercial trials
Drug classes (ATC)
L
Oncology (ATC L)
1
Mechanism of action (INN-stem analysis)
Unknown / small molecule
2 substances
Alkylating agent
1 substance
Checkpoint inhibitor (CTLA-4)
1 substance
Checkpoint inhibitor (PD-1)
1 substance
Phase II:
1
Phase II
1 trial-
RecruitingiOnctura SA CommercialDACARBAZINE CITRATE; IPILIMUMAB; NIVOLUMAB; NIVOLUMAB, RELATLIMAB; ROGINOLISIB
Sponsor activity
| Sponsor | Type | Trials | Phases | Recruiting |
|---|---|---|---|---|
| iOnctura SA | Commercial | 1 | Phase II | 1 |
New trials by year
2025
1